Adverum Biotechnologies, Inc.
ADVM
Revenue
1.00M
▲1.00M∞%
3 Months ChangeAssets
234.38M
▼-19.43M▼-7.65%
3 Months ChangeLiabilities
90.26M
▲4.49M▲5.23%
3 Months ChangeFree Cash Flow
-23.34M
▼-838.00k▼-3.72%
12 Months ChangeRevenue/Cost Of Revenue
Loading...
Net Profit/Loss
Loading...
Assets/Liabilities
Loading...
Cash Flows
Loading...
Loading...
Loading...
Recent Quarterly and Annual Filings
2024-08-12
Form 10-Q
ID: 0001628280-24-036769
2024-08-12
Form 8-K
ID: 0001628280-24-036763
2024-07-17
Form 8-K
ID: 0001193125-24-180412
2024-06-18
Form 8-K
ID: 0001193125-24-163397
2024-06-11
Form 8-K
ID: 0001193125-24-159134
2024-05-09
Form 10-Q
ID: 0001628280-24-022236
2024-05-09
Form 8-K
ID: 0001628280-24-022224
2024-03-20
Form 8-K
ID: 0001193125-24-072709
2024-03-18
Form 8-K
ID: 0001628280-24-011646
2024-02-08
Form 8-K
ID: 0001193125-24-027649